4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Heron Therapeutics, Inc. (HRTX) operates in the Biotechnology industry and is headquartered in Cary, United States with about 128 employees. Its market capitalization is roughly $81 million. In the fiscal year ended 2025-12-31, HRTX reported $155M in revenue and ($20M) in net income.
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
Interactive charts & full statements → Open the HRTX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $155M | $144M | $127M | $108M |
| Gross Profit | $114M | $106M | $62M | $53M |
| Operating Income (EBIT) | ($2M) | ($12M) | ($111M) | ($175M) |
| Net Income | ($20M) | ($14M) | ($111M) | ($182M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $35M | $41M | $38M | $37M | $39M |
| Gross Profit | $24M | $30M | $26M | $27M | $30M |
| Operating Income (EBIT) | ($5M) | $0M | ($4M) | ($2M) | $3M |
| Net Income | ($8M) | ($3M) | ($18M) | ($2M) | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $256M | $233M | $222M | $251M | — |
| Total Liabilities | $242M | $267M | $256M | $237M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HRTX viewer.
About TickerBase · Data methodology & sources